TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 78 filers reported holding TRANSLATE BIO INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,018,000 | +63.3% | 145,901 | -2.2% | 0.00% | +100.0% |
| Q1 2021 | $2,460,000 | +11.9% | 149,194 | +25.0% | 0.00% | 0.0% |
| Q4 2020 | $2,199,000 | -55.3% | 119,380 | -67.0% | 0.00% | -66.7% |
| Q3 2020 | $4,919,000 | +862.6% | 361,478 | +1166.3% | 0.00% | – |
| Q2 2020 | $511,000 | +312.1% | 28,546 | +130.9% | 0.00% | – |
| Q1 2020 | $124,000 | +22.8% | 12,361 | -1.6% | 0.00% | – |
| Q4 2019 | $101,000 | +23.2% | 12,567 | +50.4% | 0.00% | – |
| Q3 2019 | $82,000 | -68.7% | 8,353 | -59.9% | 0.00% | – |
| Q2 2019 | $262,000 | -25.6% | 20,856 | -40.0% | 0.00% | – |
| Q1 2019 | $352,000 | +458.7% | 34,740 | +307.6% | 0.00% | – |
| Q4 2018 | $63,000 | -84.9% | 8,523 | -79.6% | 0.00% | – |
| Q3 2018 | $417,000 | – | 41,865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 3,922,008 | $39,102,000 | 52.94% |
| Omega Fund Management, LLC | 2,437,603 | $24,303,000 | 10.06% |
| Baupost Group | 17,544,239 | $171,071,000 | 2.52% |
| FRAZIER MANAGEMENT LLC | 2,182,789 | $21,762,000 | 2.47% |
| RTW INVESTMENTS, LP | 3,692,424 | $36,813,000 | 1.58% |
| Camber Capital Management LP | 1,765,000 | $17,597,000 | 1.05% |
| Bain Capital Public Equity Management II, LLC | 416,670 | $4,154,000 | 0.49% |
| Rock Springs Capital Management LP | 825,000 | $8,225,000 | 0.34% |
| Birchview Capital, LP | 30,000 | $299,000 | 0.26% |
| Artal Group S.A. | 600,000 | $5,982,000 | 0.25% |